This inventor holds 2 USPTO granted patents. Top assignee: Tsumura Juntendo, Inc.. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: Eiko Itoh: Innovator in Cancer Treatment Solutions
Introduction
Eiko Itoh is a notable inventor based in Nagareyama, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a focus on improving the quality of life for tumor-bearing patients, Itoh has developed compositions that aim to alleviate cancer symptoms.
Latest Patents
Eiko Itoh holds 2 patents that showcase his dedication to advancing cancer treatment. His latest patents include:
1. **Preparation for Reducing Cancer Symptoms Without Treating Cancer**: This composition is designed to improve lipid metabolism and reduce anorexia in patients with tumors. It utilizes an aqueous or aqueous organic solvent extract from various crude preparations, including Astragali radix, Cinnamomi cortex, and Ginseng radix, among others. The method aims to inhibit the lipid degradation-promoting action of toxohormone L.
2. **Adminiculum for Antitumor Agents**: This invention enhances the antitumor activities of mitomycin C and doxorubicin hydrochloride while minimizing their side effects. It also comprises an extract from the same group of crude preparations and outlines methods for both preparation and use.
Career Highlights
Eiko Itoh is associated with Tsumura Juntendo, Inc., where he continues to work on innovative solutions for cancer treatment. His research is pivotal in developing effective therapies that address the challenges faced by patients undergoing cancer treatment.
Collaborations
Itoh collaborates with esteemed colleagues, including Masaki Aburada and Shigefumi Takeda. Their combined expertise contributes to the advancement of cancer treatment methodologies.
Conclusion
Eiko Itoh's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer treatment. His patents reflect a commitment to improving patient outcomes and enhancing the quality of life for those affected by cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile